JPMorgan Chase & Co’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,248
| Closed | -$31.4K | – | 6178 |
|
|
2025
Q1 | $31.4K | Buy |
20,248
+1,319
| +7% | +$2.04K | ﹤0.01% | 5165 |
|
|
2024
Q4 | $40.5K | Buy |
18,929
+1,355
| +8% | +$2.9K | ﹤0.01% | 5077 |
|
|
2024
Q3 | $76.4K | Buy |
17,574
+1,657
| +10% | +$7.21K | ﹤0.01% | 4830 |
|
|
2024
Q2 | $74.2K | Buy |
15,917
+6,428
| +68% | +$30K | ﹤0.01% | 4746 |
|
|
2024
Q1 | $48.1K | Sell |
9,489
-812,145
| -99% | -$4.12M | ﹤0.01% | 4993 |
|
|
2023
Q4 | $2.31M | Sell |
821,634
-285,949
| -26% | -$804K | ﹤0.01% | 3058 |
|
|
2023
Q3 | $3.18M | Buy |
1,107,583
+27,524
| +3% | +$79K | ﹤0.01% | 2710 |
|
|
2023
Q2 | $5.45M | Buy |
1,080,059
+1,079,507
| +195,563% | +$5.45M | ﹤0.01% | 2434 |
|
|
2023
Q1 | $1K | Hold |
552
| – | – | ﹤0.01% | 5619 |
|
|
2022
Q4 | $1K | Sell |
552
-1,474
| -73% | -$2.67K | ﹤0.01% | 5422 |
|
|
2022
Q3 | $3K | Buy |
2,026
+514
| +34% | +$761 | ﹤0.01% | 5266 |
|
|
2022
Q2 | $4K | Sell |
1,512
-258,960
| -99% | -$685K | ﹤0.01% | 5330 |
|
|
2022
Q1 | $723K | Buy |
260,472
+62,877
| +32% | +$175K | ﹤0.01% | 3799 |
|
|
2021
Q4 | $1.05M | Sell |
197,595
-14,656
| -7% | -$78.2K | ﹤0.01% | 3642 |
|
|
2021
Q3 | $1.8M | Sell |
212,251
-67,253
| -24% | -$569K | ﹤0.01% | 3245 |
|
|
2021
Q2 | $3.41M | Sell |
279,504
-72,356
| -21% | -$882K | ﹤0.01% | 2885 |
|
|
2021
Q1 | $8.54M | Sell |
351,860
-6,993
| -2% | -$170K | ﹤0.01% | 2256 |
|
|
2020
Q4 | $11.5M | Buy |
358,853
+154,911
| +76% | +$4.96M | ﹤0.01% | 1835 |
|
|
2020
Q3 | $6.2M | Buy |
203,942
+130,245
| +177% | +$3.96M | ﹤0.01% | 2063 |
|
|
2020
Q2 | $3.11M | Sell |
73,697
-26,689
| -27% | -$1.13M | ﹤0.01% | 2450 |
|
|
2020
Q1 | $2.5M | Buy |
+100,386
| New | +$2.5M | ﹤0.01% | 2450 |
|